跳至主要内容
临床试验/ACTRN12612001018808
ACTRN12612001018808已完成4 期

A 6 month evaluation of pentoxifylline (Trental) treatment for anaemia of chronic kidney disease

Professor John OLYNYK FRACP MD0 个研究点目标入组 44 人开始时间: 2012年9月20日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients will be eligible for inclusion if they fulfil the following criteria: between 18 and 80 years of age; glomerular filtration rate < 45 ml/min, stable known renal function over last 12 months; not requiring haemodialysis; haemoglobin < 120 g/L(Female), <130 g/L(Male); ferritin > 100 microg/L or transferrin saturation > 20% and not currently receiving ESA.

排除标准

  • Exclusion criteria include: significant co-morbid conditions which in the opinion of the treating nephrologist preclude inclusion in the study; active gastrointestinal bleeding or another source of blood loss; haemolysis or other haematological disorder which reduces haemoglobin level; pregnancy or lactation. Intolerance to methlanthines (eg. caffeine, theophylline), recent peptic ulcer, recent cerebral or retinal haemorhage and acute MI.

研究者

发起方
Professor John OLYNYK FRACP MD

相似试验